Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27.6M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
8.09M
-
Shares change
-
-448K
-
Total reported value, excl. options
-
$2.26M
-
Value change
-
-$124K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$0.28
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q4 2023
14 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q4 2023.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.09M shares
of 27.6M outstanding shares and own 29.3% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.52M shares), JOHNSON & JOHNSON (2.13M shares), 8VC GP I, LLC (1.09M shares), RENAISSANCE TECHNOLOGIES LLC (110K shares), MMCAP International Inc. SPC (96.8K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (49.5K shares), CITADEL ADVISORS LLC (33.6K shares), Walleye Capital LLC (21.1K shares), XTX Topco Ltd (14.5K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.9K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.